Transform Pharma Possibilities with Aragen

Meet Us at CPHI Frankfurt 2025

Date: October 28-30, 2025 | Location: Messe Frankfurt

Booth No: 5.0C24

Welcome to Aragen

Where Molecules Meet Momentum

Step into the future of pharma with Aragen—a leading full-service Contract Research, Development, and Manufacturing Organization (CRDMO), uniquely positioned to accelerate your drug discovery, development, and commercial manufacturing programs for small and large molecules.

With global footprints in India and the USA, Aragen delivers seamless, integrated solutions powered by advanced technologies, sustainable supply chains, and AI-driven innovation. We bring your drug programs to life faster and smarter.

Meet Us at CPHI Frankfurt 2025

Our Expertise

Your unified CRDMO partner offering end-to-end, scalable solutions across the entire drug lifecycle — all under one roof:

  • Discovery & Preclinical Research: Rapid candidate identification and early-stage development
  • Process R&D & Analytical Services: Innovative process optimization and precise analytics
  • Formulation & Regulatory Support: Tailored drug product development and seamless regulatory navigation
  • GMP Manufacturing: Clinical to commercial scale production for small molecules and biologics
  • GLP Safety & Toxicology Studies: Comprehensive safety assessment to meet global standards
  • Supply Chain Strategy & Tech Transfer: Intelligent, resilient logistics and smooth technology transfer
Process Development & Scale-Up
  • Route scouting, optimization, and technology transfer
  • Phase-appropriate process and analytical development
  • QbD and DoE-based scale-up strategies
  • 600+ m³ of total reactor volume across 5 GMP-certified sites
  • 360 KL reactor capacity across 3 globally accredited sites
  • Support for 100+ preclinical to commercial programs annually
  • 300+ chemists and engineers across process R&D and analytical functions
  • Proven track record in seamless scale-up to clinical and commercial launch
  • Accredited by USFDA, EMA, WHO, PMDA, and ISO
GMP Manufacturing
  • Clinical drug product manufacturing & integrated DS/DP
  • Clinical and commercial production of APIs & intermediates
  • Batch sizes ranging from gram-scale to multi-ton scale
  • Expertise in non-GMP/GMP KSMs, intermediates, and APIs
  • Integrated DS/DP manufacturing to seamlessly offer quick to clinic option
  • Expertise in developing early (FIH) and late phase (2B) clinical drug product
  • Digital QC labs with LIMS integration for operational transparency
  • Multi-site operations in India and the U.S. for global supply continuity
  • Leveraging Golden Batch Analytics powered by AI/ML
Formulation Services
  • Comprehensive support from pre-formulation (salt and polymorph screening), preclinical formulation (reg tox) and clinical drug product dev & manufacturing (phase 1 to 2B)
  • Solutions for bioavailability enhancement: Spray Dried Dispersions (SDDs), micro- & nano-sized suspensions/emulsions, oral peptide delivery
  • Broad dosage form expertise: Oral solids, injectables, topicals, injectables, long-acting injectables (LAI)
  • State-of-the-art cGMP formulation facility: Mfg and supply of IR/MR tablets, film‑coated tablets, capsules (neat, blends, pellets), DiC, DiB, mini‑tablets and SDD-based products for clinical trials
Specialized Capabilities
  • HPAPIs & cytotoxics handled in dedicated high-containment suites
  • Advanced chemistry platforms: Flow chemistry, biocatalysis, and process safety
  • Complex chemistries: Peptides, oligonucleotides, and ADC payloads
  • Solving formulation challenges-Spray drying and nano-technology solutions from R&D to GMP mfg scale
Discovery & Early Development
  • CHOMax™ with Fut∞KO: A glycoengineered GS knockout platform enabling enhanced ADCC and cost-effective therapeutics
  • Aragen platform delivers 8 g/L single-cell clone titers within 16 weeks and >25 g/L post N-stage intensification
  • Royalty-free CHO DG44 and CHO GS platforms with a successful track record of 200+ cell line development projects
  • High-throughput antibody screening, immunogen generation, and monoclonality assessment using Cytena and Solentim technologies
  • Transient and stable expression systems in CHO, HEK, Expi, and hybridoma cells
Bioproduction & Process Development
  • Comprehensive gene synthesis to protein delivery at mg to kg scale with various bioreactor systems (wave, bench-top, SUBs 50L–250L)
  • State-of-the-art single-use GMP manufacturing: clinical scale 200 L, 500 L and 2,000 L and commercial scale (2,000 L), with expandable capacity up to 23 KL
  • High productivity with minimum titers of 4 g/L for most mAbs and BsAbs, scaling up to 25 g/L after process intensification
  • Proven expertise across multiple biologic formats: mAbs, bispecifics, trispecifics, fusion proteins, enzymes, hormone receptors, and more
  • ISO 9001–certified facility ensuring quality and compliance
Analytical Development & Characterization
  • Advanced analytical labs for biochemical and biophysical characterization
  • Platform and customized method development, qualification, and validation aligned with regulatory requirements
  • Comprehensive formulation development, stability studies, and stress testing including pH, agitation, freeze-thaw, and photostability
  • Expertise in biosimilar comparability and GMP/non-GMP stability support
Specialized Capabilities
  • Perfusion technology at various scales for seed intensification and production stages
  • Virus clearance studies using robust scale-down models and worst-case scenario evaluations
  • Material equivalency and process intensification studies to optimize upstream and downstream workflows
  • Rigorous cross-contamination mitigation and dedicated AHUs for rapid and safe product changeover

Standalone Comprehensive Analytical Support

  • Method Development & Validation: ICH-compliant, including nitrosamine and genotoxic impurity profiling
  • Extractables & Leachables: Characterization of packaging, devices, and dosage forms
  • Microbiology & Dissolution: MLT, BET, sterility, kill rate, and USP I–IV dissolution testing
  • Stability Testing: cGMP stability and photostability programs supported by 100,000 L facility
  • Advanced Instrumentation: LC-MS/MS, GC-MS, ICP-MS, QTOF, Orbitrap
  • Quality & Regulatory Excellence: Accredited by USFDA, PMDA, WHO, NABL, CDSCO with ISO 17025-aligned QMS, zero Form 483s (2019 & 2025), and 200+ GMP audits since 2017

Walk-ins are welcome, but if you'd prefer to schedule a meeting, please fill in your details to secure a slot.

We look forward to seeing you at the show and discussing how we can support your journey from development to market!

Meet Us at CPHI Frankfurt 2025

Building a Resilient & Sustainable Supply Chain

At Aragen, we’re redefining pharma supply chain excellence with a focus on resilience, sustainability, and digital innovation to ensure your molecules reach patients reliably and responsibly.

...

Hyper-Local & Diversified Sourcing

  • 42% of sourcing is hyper-local (within 200 km)
  • Reduced import dependency from ~60% to ~10% in five years
  • 54% supplier diversity with robust performance tracking
...

Sustainability at the Core

  • EcoVadis score of 80 (top 1% globally)
  • CDP 2024 A-List for supplier engagement
  • SAF adoption and green fuel logistics expansion
  • Scorecard-based assessment for partners and internal teams
...

Digitally-driven Efficiency

  • Fully digitalized source-to-pay (SAP ARIBA & S4 HANA)
  • AI-enabled sourcing and RPA-automated workflows
  • Real-time shipment tracking (inbound & outbound)
  • E-auctions and global compliance screening
...

Global Coordination Advantage

  • US time zone operations for seamless India–US flow
  • EOU & SEZ benefits for agile, cost-effective delivery
  • Strategic global logistics for supply continuity

Join us at CPHI Frankfurt 2025 to discover how Aragen’s resilient supply chain accelerates your pharma programs, from molecule to market.

Certifications & Sustainability Commitment

Aragen is committed to sustainable and responsible business practices

img

Aragen's Leadership Presence at CPHI

Meet our team of experts who will be present at CPHI Frankfurt 2025. Connect with us to discuss your drug development challenges.

img
Manni Kantipudi

MD & CEO

img
Ashu Tandon

Chief Commercial Officer

img
Subodh Deshmukh

CEO, Biologics Solutions

img
Aniel Khubchandani

CEO, Development & Manufacturing Solutions

img
Jayadeva Sajankila

VP & Head, Chemical Development Solutions

img
Vaibhav Sihorkar

VP & Head, Formulations Solutions

img
D Vijaya Bharathi

SVP & Head, Analytical Solutions

img
Naveen Kumar Annam

VP & Head, Custom Manufacturing Solutions

img
Srinivas Reddy Mamidi

Business Development, Global Head - Key Accounts

img
Amar Karandikar

SVP and Global BD Head, Small Molecule Development and Manufacturing

img
Jamie Cascio

AVP, Business Development, Biologics

Unlock the Future of Drug Development with Aragen

Meet Us at CPHI Frankfurt 2025 | Booth 5.0 C24

Discover how Aragen, a global CRDMO leader, is accelerating pharmaceutical innovation—from molecule to market. Whether you're a biotech startup or a global pharma, we provide end-to-end support across the drug development lifecycle.

Your Science. Our Solutions.

Let’s Innovate Together

Contact us now

Feel free to email us at info@aragen.com or fill out the contact form to discuss how we can accelerate your program from concept to commercial.

Driving Next-Generation Digital Manufacturing at Aragen

At Aragen, our digital ecosystem seamlessly integrates cutting-edge technologies with human creativity and expertise to accelerate drug discovery, development, and manufacturing. We focus on empowering people with intelligent tools to deliver agile, transparent, and quality-driven solutions across the pharma value chain.

Our Smart Digital Platforms Empowering Every Step
  • Innovative Digital Labs: Advanced labs that enhance decision-making and collaboration through integrated AI tools and connected robotics
  • Dynamic Project Management: Real-time, flexible workflows designed to streamline communication and optimize project delivery
  • Intuitive Electronic Lab Notebooks: AI-augmented documentation systems that simplify data capture, analysis, and team collaboration
  • Comprehensive Sample & Instrument Management: Integrated platforms combining predictive analytics with expert oversight to ensure consistency and efficiency
  • Robust Laboratory Information Management: User-friendly systems that support data integrity, compliance, and actionable insights
Enriching Customer Experiences through Digital Innovation
  • Personalized Customer Support Platforms: Interactive and responsive tools fostering co-creative partnerships and rapid issue resolution
  • Secure Data & IP Management: Strong cybersecurity protocols protecting your valuable information with utmost confidentiality
  • Intuitive Electronic Lab Notebooks: AI-augmented documentation systems that simplify data capture, analysis, and team collaboration
  • Comprehensive Sample & Instrument Management: Integrated platforms combining predictive analytics with expert oversight to ensure consistency and efficiency
  • Robust Laboratory Information Management: User-friendly systems that support data integrity, compliance, and actionable insights
Meet Us at CPHI Frankfurt 2025